Skip to content
  • About
  • Contact
  • Our Staff
  • Advertise
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Author: Gurinder Khera

As the Founder of US Pharma Marketing, I launched the platform to address a clear gap in the pharmaceutical, biotech, and life sciences industries: a centralized resource for marketing and sales insights tailored to the unique challenges of these sectors.With the rapid growth and increasing complexity of these industries, professionals need up-to-date, expert-driven content that empowers them to navigate emerging trends, regulatory changes, and evolving customer expectations. At US Pharma Marketing, we provide the latest industry updates, in-depth analysis, actionable strategies, and expert advice, helping professionals stay competitive and innovative.Our platform serves marketers, sales leaders, and business professionals across pharma, biotech, and life sciences, offering the tools they need to drive growth and success in a fast-paced healthcare landscape.
GLP-1 and the Obesity Market: The Sales Playbook Behind Pharma’s New Gold Rush
Posted in
  • Digital Transformation
  • Industry Landscape

GLP-1 and the Obesity Market: The Sales Playbook Behind Pharma’s New Gold Rush

The world’s largest pharmaceutical companies have found their new gold rush, and it’s not oncology this … GLP-1 and the Obesity Market: The Sales Playbook Behind Pharma’s New Gold RushRead more

by Gurinder Khera•October 4, 2025October 4, 2025•0
M&A Activity Boosting Biotech Sales Pipelines: How High-Stakes Deals Are Reshaping Pharma Innovation
Posted in
  • Case Studies & Trends
  • Industry Landscape
  • Job & Career

M&A Activity Boosting Biotech Sales Pipelines: How High-Stakes Deals Are Reshaping Pharma Innovation

When Genmab announced its $8 billion acquisition of Merus, industry analysts didn’t just see another consolidation … M&A Activity Boosting Biotech Sales Pipelines: How High-Stakes Deals Are Reshaping Pharma InnovationRead more

by Gurinder Khera•October 4, 2025October 4, 2025•0
Direct-to-Consumer Advertising Oversight: How FDA’s Crackdown Is Redefining Pharma Marketing
Posted in
  • Industry Landscape
  • Strategy & Execution

Direct-to-Consumer Advertising Oversight: How FDA’s Crackdown Is Redefining Pharma Marketing

The glossy world of pharmaceutical advertising is facing its biggest regulatory reset in two decades. For … Direct-to-Consumer Advertising Oversight: How FDA’s Crackdown Is Redefining Pharma MarketingRead more

by Gurinder Khera•October 4, 2025October 4, 2025•0
Oncology Drug Sales Boom: How mAbs, ADCs, and ICIs Are Reshaping Commercial Strategy
Posted in
  • Digital Transformation
  • Industry Landscape

Oncology Drug Sales Boom: How mAbs, ADCs, and ICIs Are Reshaping Commercial Strategy

The oncology commercial landscape is entering a high-velocity phase. You may have seen dramatic headlines: double-digit … Oncology Drug Sales Boom: How mAbs, ADCs, and ICIs Are Reshaping Commercial StrategyRead more

by Gurinder Khera•September 30, 2025September 30, 2025•0
Sales Training Evolution in Life Sciences: How Retro-Inspired, Interactive Workshops Are Shaping the Future of Pharma & Biotech Teams
Posted in
  • Digital Transformation
  • Job & Career

Sales Training Evolution in Life Sciences: How Retro-Inspired, Interactive Workshops Are Shaping the Future of Pharma & Biotech Teams

When a room full of experienced pharma reps sits in circle-shifted cubicles, decked out with flip-charts, … Sales Training Evolution in Life Sciences: How Retro-Inspired, Interactive Workshops Are Shaping the Future of Pharma & Biotech TeamsRead more

by Gurinder Khera•September 30, 2025September 30, 2025•0
AI-Driven Personalization in Pharma Marketing: Building Trust Through Data and Responsiveness
Posted in
  • Digital Transformation
  • Industry Landscape

AI-Driven Personalization in Pharma Marketing: Building Trust Through Data and Responsiveness

Walk into any discussion with senior leaders in pharma today, and one theme dominates the room: … AI-Driven Personalization in Pharma Marketing: Building Trust Through Data and ResponsivenessRead more

by Gurinder Khera•September 29, 2025September 29, 2025•0
Europe and U.K. Ignite a New Era of Talent Magnetism: How Financial Incentives Draw U.S. Scientists Abroad
Posted in
  • Industry Landscape
  • Strategy & Execution

Europe and U.K. Ignite a New Era of Talent Magnetism: How Financial Incentives Draw U.S. Scientists Abroad

When you glance at job boards for life-science positions, you’ll notice something shifting—not a trickle, but … Europe and U.K. Ignite a New Era of Talent Magnetism: How Financial Incentives Draw U.S. Scientists AbroadRead more

by Gurinder Khera•September 24, 2025September 24, 2025•0
How Pharma Must Reimagine Its Role in the $1 Trillion Healthcare Reinvention
Posted in
  • Case Studies & Trends
  • Digital Transformation
  • Industry Landscape

How Pharma Must Reimagine Its Role in the $1 Trillion Healthcare Reinvention

Imagine waking up five years from now and realizing that the pharmaceutical industry you thought you … How Pharma Must Reimagine Its Role in the $1 Trillion Healthcare ReinventionRead more

by Gurinder Khera•September 24, 2025September 24, 2025•0
How Agentic AI Is Redefining Pharma Clinical Trials: A Deep Dive into Medable’s Approach and the Road Ahead
Posted in
  • Industry Landscape
  • Regulatory Compliance
  • Strategy & Execution

How Agentic AI Is Redefining Pharma Clinical Trials: A Deep Dive into Medable’s Approach and the Road Ahead

Why do clinical trials—arguably the most critical phase of drug development—still depend on outdated, manual oversight? … How Agentic AI Is Redefining Pharma Clinical Trials: A Deep Dive into Medable’s Approach and the Road AheadRead more

by Gurinder Khera•September 24, 2025September 24, 2025•0
How Pharma Marketers Are Harnessing AI for Content Efficiency — And Navigating the Risks
Posted in
  • Digital Transformation
  • Industry Landscape

How Pharma Marketers Are Harnessing AI for Content Efficiency — And Navigating the Risks

The pace of pharma marketing has never been more unforgiving. Content demands are multiplying across channels, … How Pharma Marketers Are Harnessing AI for Content Efficiency — And Navigating the RisksRead more

by Gurinder Khera•September 24, 2025September 24, 2025•0

Posts pagination

Previous 1 2 3 … 5 Next

Recent Posts

  • Biopharma Layoffs: Optimizing Sales Teams Amid Workforce Shifts
  • Competitive Intelligence Surge: Elevating Pharma Marketing Insights
  • Eli Lilly Trades AI Access for Biotech Data to Drive Precision Marketing in Obesity and Alzheimer’s
  • FDA’s Crackdown on Pharma’s Digital Marketing: What the Warning Letters to Lilly, Novo, and Novartis Signal for the Future of DTC Advertising
  • Top-Selling Biotech Drugs & Revenue Forecasts: Tracking Blockbusters and the Road Ahead

Recent Comments

No comments to show.
Copyright © 2025 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A